NCT00638248View on ClinicalTrials.gov

Dose Escalation of Desmoteplase in Acute Ischemic Stroke (DEDAS)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions
Stroke
Interventions
DRUG

Desmoteplase

Desmoteplase 90µg/kg BW i.v. bolus

DRUG

Desmoteplase

Desmoteplase 125 µg/kg BW i.v. bolus

DRUG

Placebo

Placebo i.v. bolus

All Listed Sponsors
lead

PAION Deutschland GmbH

INDUSTRY

NCT00638248 - Dose Escalation of Desmoteplase in Acute Ischemic Stroke (DEDAS) | Biotech Hunter | Biotech Hunter